These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29133340)

  • 1. Effects of hawthorn ( Crataegus pentagyna) leaf extract on electrophysiologic properties of cardiomyocytes derived from human cardiac arrhythmia-specific induced pluripotent stem cells.
    Pahlavan S; Tousi MS; Ayyari M; Alirezalu A; Ansari H; Saric T; Baharvand H
    FASEB J; 2018 Mar; 32(3):1440-1451. PubMed ID: 29133340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell-derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R.
    Zhang XH; Wei H; Xia Y; Morad M
    Heart Rhythm; 2021 Feb; 18(2):250-260. PubMed ID: 32931925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.
    Fatima A; Xu G; Shao K; Papadopoulos S; Lehmann M; Arnáiz-Cot JJ; Rosa AO; Nguemo F; Matzkies M; Dittmann S; Stone SL; Linke M; Zechner U; Beyer V; Hennies HC; Rosenkranz S; Klauke B; Parwani AS; Haverkamp W; Pfitzer G; Farr M; Cleemann L; Morad M; Milting H; Hescheler J; Saric T
    Cell Physiol Biochem; 2011; 28(4):579-92. PubMed ID: 22178870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
    Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O
    J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay.
    Long SR; Carey RA; Crofoot KM; Proteau PJ; Filtz TM
    Phytomedicine; 2006 Nov; 13(9-10):643-50. PubMed ID: 16487691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.
    Itzhaki I; Maizels L; Huber I; Gepstein A; Arbel G; Caspi O; Miller L; Belhassen B; Nof E; Glikson M; Gepstein L
    J Am Coll Cardiol; 2012 Sep; 60(11):990-1000. PubMed ID: 22749309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro chronotropic effects of Erythrina senegalensis DC (Fabaceae) aqueous extract on mouse heart slice and pluripotent stem cell-derived cardiomyocytes.
    Nembo EN; Atsamo AD; Nguelefack TB; Kamanyi A; Hescheler J; Nguemo F
    J Ethnopharmacol; 2015 May; 165():163-72. PubMed ID: 25680843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium signaling in human stem cell-derived cardiomyocytes: Evidence from normal subjects and CPVT afflicted patients.
    Zhang XH; Morad M
    Cell Calcium; 2016 Mar; 59(2-3):98-107. PubMed ID: 26725479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.
    Maizels L; Huber I; Arbel G; Tijsen AJ; Gepstein A; Khoury A; Gepstein L
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
    Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
    J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.
    Sinnecker D; Goedel A; Laugwitz KL; Moretti A
    Circ Res; 2013 Mar; 112(6):961-8. PubMed ID: 23569105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges.
    Friedrichs S; Malan D; Sasse P
    Trends Cardiovasc Med; 2013 May; 23(4):91-8. PubMed ID: 23266156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hawthorn (Crataegus monogyna Jacq.) extract exhibits atropine-sensitive activity in a cultured cardiomyocyte assay.
    Salehi S; Long SR; Proteau PJ; Filtz TM
    J Nat Med; 2009 Jan; 63(1):1-8. PubMed ID: 18696181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a
    Gélinas R; El Khoury N; Chaix MA; Beauchamp C; Alikashani A; Ethier N; Boucher G; Villeneuve L; Robb L; Latour F; Mondesert B; Rivard L; Goyette P; Talajic M; Fiset C; Rioux JD
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29021306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
    Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
    Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Duncan G; Firth K; George V; Hoang MD; Staniforth A; Smith G; Denning C
    Stem Cells Dev; 2017 Dec; 26(23):1695-1705. PubMed ID: 28992755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.
    Sallam K; Li Y; Sager PT; Houser SR; Wu JC
    Circ Res; 2015 Jun; 116(12):1989-2004. PubMed ID: 26044252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
    Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities.
    Kitaguchi T; Moriyama Y; Taniguchi T; Ojima A; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Morita M; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Tanaka K; Washio I; Miyamoto N
    J Pharmacol Toxicol Methods; 2016; 78():93-102. PubMed ID: 26657830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.